Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christine Dirienzo"'
Autor:
Sebastian Grosicki, Su-Peng Yeh, Shang-Yi Huang, Ja Min Byun, Christine Dirienzo, Andrea Viqueira
Publikováno v:
HemaSphere, Vol 7, p e039274c (2023)
Externí odkaz:
https://doaj.org/article/fcd637e7741b4f3d97c0e15bec85e6b0
Autor:
Geoffrey Chan, Hervé Dombret, Barbara Sleight, Xiaoxi Zhang, Mikkael A. Sekeres, Timothy J Bell, Eric Leip, Christine DiRienzo, Naveed Shaik, Akil Merchant, Tetsuzo Tauchi, Jorge E. Cortes
Publikováno v:
Future Oncology. 15:3531-3545
Glasdegib, an oral Hedgehog pathway inhibitor, has been associated with significantly improved survival when combined with low-dose cytarabine in patients with untreated acute myeloid leukemia (AML) who were unsuitable for intensive chemotherapy, whe
Autor:
Hironobu Minami, Naveed Shaik, Catriona Jamieson, Norio Komatsu, Ellen K. Ritchie, Mark L. Heaney, Michael W. Deininger, Moshe Talpaz, Christine DiRienzo, Mirjana Zeremski, Yun Su, Tetsuzo Tauchi, Ruben A. Mesa, Aaron T. Gerds, Geoffrey Chan, Xiaoxi Zhang
Publikováno v:
Leuk Res
Glasdegib is a potent and selective oral inhibitor of the Hedgehog pathway. We report data from the single-arm, lead-in cohort of an open-label phase 1b/2 trial of glasdegib in patients with primary/secondary myelofibrosis (MF) previously treated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02252aa9cee578067d1ba41cb89fa30c
https://europepmc.org/articles/PMC8148985/
https://europepmc.org/articles/PMC8148985/
Autor:
Moshe Talpaz, Geoffrey Chan, Catriona Jamieson, Xiaoxi Zhang, Michael W. Deininger, Ruben A. Mesa, Yun Su, Hironobu Minami, Christine DiRienzo, Ellen K. Ritchie, Naveed Shaik, Tetsuzo Tauchi, Mark L. Heaney, Aaron T. Gerds, Mirjana Zeremski, Norio Komatsu
Publikováno v:
Leuk Res
Glasdegib is a potent and selective oral inhibitor of the Hedgehog pathway. We report data from the single-arm, lead-in cohort of an open-label phase 1b/2 trial of glasdegib in patients with primary/secondary myelofibrosis (MF) previously treated wit
Autor:
Yun Su, Geoffrey Chan, Mohammed Naveed Shaik, Xiaoxi Zhang, Christine DiRienzo, Catriona Jamieson, Tetsuzo Tauchi, Moshe Talpaz, Mark L. Heaney, Norio Komatsu, Michael W. Deininger, Adrian Woolfson, Mirjana Zeremski, Ellen K. Ritchie, Ruben A. Mesa, Aaron T. Gerds, Hironobu Minami
Publikováno v:
Journal of Clinical Oncology. 35:7061-7061
7061 Background: Glasdegib is a small molecule inhibitor of the Sonic Hedgehog pathway, and data from the single arm, lead-in cohort of a phase 1b/2 trial in myelofibrosis (MF) are shown. Methods: Patients (age ≥18 yrs) with primary/secondary MF pr